Controlling amyloid growth in multiple dimensions

Amyloid

Volumn 13, Issue 4, 2006, Pages 206-215

  Dong, Jijun ^a   Lu, Kun ^a   Lakdawala, Ami ^a,b   Mehta, Anil K ^a   Lynn, David G ^a  

^a EMORY UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

sheet; Amyloid fibrils; Lamination; Nanotube; Ribbon; Structure

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42];

ALZHEIMER DISEASE; AMYLOIDOGENESIS; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CHEMICAL MODEL; HUMAN; NUCLEAR MAGNETIC RESONANCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; PROTON TRANSPORT; REVIEW; RISK FACTOR; SIMULATION; STRUCTURE ANALYSIS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID; AMYLOID BETA-PROTEIN; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; ZINC;

EID: 33751079620     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120600960809     Document Type: Review

References (69)

1. Carrell RW, Lomas DA. Conformational disease. Lancet 1997;350:134-138.
2. Kelly JW. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 1998;8:101-106.
3. Carrell RW, Gooptu B. Conformational changes and disease - serpins, prions and Alzheimer's. Curr Opin Struct Biol 1998;8:799-809.
4. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004;10:S10-17.
5. Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods 2004;34:151-160.
6. Koppel R. Alzheimer's disease: The costs to U.S. businesses in 2002. 2002. The Alzheimer's Association.
7. Nunan J, Small DH. Regulation of APP cleavage by α-, β- and γ-secretases. FEBS Lett 2000;483:6-10.
8. Saido TC, YamaoHarigaya W, Iwatsubo T, Kawashima S. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci Lett 1996;215:173-176.
9. Asami-Odaka A, Ishibashi Y, Kikuchi T, Kitada C, Suzuki N. Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 1995;34:10272-10278.
10. Dovey HF, Suomensaari-Chrysler S, Lieberburg I, Sinha S, Keim PS. Cells with a familial Alzheimer's disease mutation produce authentic β-peptide. Neuroreport 1993;4:1039-1042.
11. Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD, Tjernberg LO, Silberring J, Gandy SE, Winblad B, Greengard P. Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA 1994;91:8378-8382.
12. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ. β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 1993;90:10836-10840.
13. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 1992;359:325-327.
14. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai XD, McKay DM, Tintner R, Frangione B, et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 1992;258:126-129.
15. Hardy J. Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr Alzheimer Res 2006;3:71-73.
16. Kirschner DA, Abraham C, Selkoe DJ. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-b conformation. Proc Natl Acad Sci USA 1986;83:503-507.
17. Inouye H, Fraser PE, Kirschner DA. Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: analysis by X-ray diffraction. Biophys J 1993;64:502-519.
18. Inouye H, Kirschner DA. Refined fibril structures: the hydrophobic core in Alzheimer's amyloid β-protein and prion as revealed by X-ray diffraction. Ciba Found Symp 1996;199:22-35.
19. Kirschner DAI, Duffy LK, Sinclair A, Lind M, Selkoe DJ. Synthetic peptide homologous to β protein from Alzheimer Disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 1987;84:6953.
20. Inouye H, Kirschner DA. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices. J Mol Biol 1997;268:375-389.
21. Nguyen JT, Inouye H, Baldwin MA, Fletterick RJ, Cohen FE, Prusiner SB, Kirschner DA. X-ray diffraction of scrapie prion rods and PrP peptides. J Mol Biol 1995;252:412-422.
22. Halverson K, Fraser PE, Kirschner DA, Lansbury PT Jr. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic β-protein fragments. Biochemistry 1990;29:2639-2644.
23. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Aggregation and secondary structure of synthetic amyloid β A4 peptides of Alzheimer's disease. J Mol Biol 1991;218:149-163.
24. Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, Meredith SC. Two-dimensional structure of β-amyloid(10-35) fibrils. Biochemistry 2000;39:3491-3499.
25. (10-35) fibril. J Am Chem Soc 2000;122:7883-7889.
26. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zurcherneely HA, Heinrikson RL, Ball MJ, Greenberg BD. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimers-disease. J Biol Chem 1993;268:3072-3083.
27. Kheterpal I, Williams A, Murphy C, Bledsoe B, Wetzel R. Structural features of the Aβ amyloid fibril elucidated by limited proteolysis. Biochemistry 2001;40:11757-11767.
28. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. Structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 2002;99:16742-16747.
29. Lynn DG, Meredith SC. Model peptides and the physico-chemical approach to β-amyloids. J Struct Biol 2000;130:153-173.
30. Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, Tycko R. Supramolecular structure in full-length Alzheimer's β-amyloid fibrils: evidence for a parallel b-sheet organization from solid-state nuclear magnetic resonance. Biophys J 2002;83:1205-1216.
31. Morgan DM, Lynn DG, Lakdawala AS, Snyder JP, Liotta DC. Amyloid structure: Models and theoretical considerations in fibrous aggregates. J Chin Chem Soc-Taip 2002;49:459-466.
32. Lakdawala AS, Morgan DM, Liotta DC, Lynn DG, Snyder JP. Dynamics and fluidity of amyloid fibrils: A model of fibrous protein aggregates. J Am Chem Soc 2002;124:15150-15151.
33. Lu K, Jacob J, Thiyagarajan P, Conticello VP, Lynn DG. Exploiting amyloid fibril lamination for nanotube self-assembly. J Am Chem Soc 2003;125:6391-6393.
34. Garzon-Rodriguez WS-B, Milton S, Glabe CG. Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J Biol Chem 1997;272:21037.
35. Fay DS, Fluet A, Johnson CJ, Link CD. In vivo aggregation of β-amyloid peptide variants. J Neurochem 1998;71:1616-1625.
36. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease β A4 peptides. J Mol Biol 1992;228:460-73.
37. Tjernberg LON, Lindqvist F, Johansson, J, Karlstrom AR, Thyberg, J, Terenius L, Nordstedt, C. Arrest of β-amyloid fibril formation by a pentapeptide ligand. J Biol Chem 1996;271:8545-8548.
38. Wood S, Wetzel R, Martin JD, Hurle M. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide. Biochemistry 1995;34:724-730.
39. Wolfe M. Therapeutic strategies for Alzheimer's disease. Nat Rev Drug Discov 2002;1:859.
40. Findeis M. Peptide inhibitors of β amyloid aggregation. Curr Top Med Chem 2002;2:417.
41. Findeis M, Musso GM, Arico-Muendel CC, Benjamin HW, Hundal AM, Lee JJ, Chin J, Kelley M, Wakefield J, Hayward NJ, Molineaux SM. Modified-peptide inhibitors of amyloid β-peptide polymerization. Biochemistry 1999;38:6791.
42. Balbach JJI, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J, Tycko R. Amyloid fibril formation by Aβ16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 2000;39:13748-13759.
43. Ma B, Nussinov R. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16-22, Aβ16-35, and Aβ10-35): Sequence effects. Proc Natl Acad Sci USA 2002;99:14126-14131.
44. Santini SM, Derreumaux P. In silico assembly of Alzheimer's Aβ16-22 peptide into β-sheets. J Am Chem Soc 2004;126:11509-11516.
45. Santini S, Mousseau N, Derreumaux P. Pathway complexity of Alzheimer's β-amyloid Aβ16-22 peptide assembly. Structure 2004;12:1245-1255.
46. Vauthey SS, Gong H, Watson, N, Zhang S. Molecular self-assembly of surfactant-like peptides to form nanotubes and nanovesicles. Proc Natl Acad Sci USA 2002;99:5355-5360.
47. Fuhrhop JHW. Fluid and solid fibers made of lipid molecular bilayers. Chem Rev 1993;93:1565.
48. Schnur JM. Lipid tubules: A paradigm for molecularly engineered structures. Science 1993;262:1669.
49. Chung DSB, Konikoff FM, Donovan JM. Elastic free energy of anisotropic helical ribbons as metastable intermediates in the crystallization of cholesterol. Proc Natl Acad Sci USA 1993;90:11341.
50. Jung JHJ, Yoshida K, Shimizu T. Self-assembling structures of long-chain phenyl glucoside influenced by the introduction of double bonds. J Am Chem Soc 2004;124:10674.
51. Frankel DAOB. Supramolecular assemblies of diacetylenic aldonamides. J Am Chem Soc 1991;113:7436.
52. Nakashima NA, Kunitake T. Optical microscopic study of helical superstructures of chiral bilayer membranes. J Am Chem Soc 1985;107:509.
53. Bush AI, Pettingell WH, Multhaup G, Paradis MD, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL, Tanzi RE. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 1994;265:1464-1467.
54. Bush AI, Pettingell WH, Paradis MD, Tanzi RE. Modulation of Aβ adhesiveness and secretase site cleavage by zinc. J Biol Chem 1994;269:12152-12158.
55. Bush AI. The metallobiology of Alzheimer's disease. Trends Neurosci 2003;26:207-214.
56. Atwood CS, Moir RD, Huang XD, Scarpa RC, Bacarra NME, Romano DM, Hartshorn MK, Tanzi RE, Bush AI. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 1998;273:12817-12826.
57. Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, Beyreuther K, Barrow CJ, Masters CL, Bush AI, Barnham KJ. Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 2001;276:20466-20473.
58. Liu ST, Howlett G, Barrow CJ. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the Aβ peptide of Alzheimer's disease. Biochemistry 1999;38:9373-9378.
59. Miura T, Suzuki K, Kohata N, Takeuchi H. Metal binding modes of Alzheimer's amyloid β-peptide in insoluble aggregates and soluble complexes. Biochemistry 2000;39:7024-7031.
60. Yang DS, McLaurin J, Qin K, Westaway D, Fraser PE. Examining the zinc binding site of the amyloid-β peptide. Eur J Biochem 2000;267:6692-6698.
61. Morgan DM, Dong J, Jacob J, Lu K, Apkarian RP, Thiyagarajan P, Lynn DG. Metal switch for amyloid formation: insight into the structure of the nucleus. J Am Chem Soc 2002;124:12644-12645.
62. Zirah S, Kozin SA, Mazur AK, Blond A, Cheminant M, Segalas-Milazzo I, Debey P, Rebuffat S. Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging. J Biol Chem 2006;281:2151-2161.
63. Aggeli A, Nyrkova IA, Bell M, Harding R, Carrick L, McLeish TC, Semenov AN, Boden N. Hierarchical self-assembly of chiral rod-like molecules as a model for peptide β-sheet tapes, ribbons, fibrils, and fibers. Proc Natl Acad Sci USA 2001;98:11857-11862.
64. Dong JJ, Shokes JE, Scott RA, Lynn DG. Modulating amyloid self-assembly and fibril morphology with Zn(II). J Am Chem Soc 2006;128:3540-3542.
65. Gazit E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J 2002;16:77-83.
66. Sacchettini JC, Kelly JW. Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov 2002;1:267-275.
67. Dobson CM. Protein folding and misfolding. Nature 2003;426:884-890.
68. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 2005;307:262-265.
69. Krishnan R, Lindquist SL. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005;435:765-772.